This grant funds interventions addressing barriers to cancer screening in populations facing health disparities, aiming to improve access and outcomes through community collaborations.
Funder: National Institutes of Health
Due Dates: November 5, 2026 (Renewal / Resubmission / Revision) | January 7, 2027 (Listing closing date)
Funding Amounts: Budgets are not limited and must reflect project needs; up to 5 years; no cost sharing required
Summary: Supports clinical trials of multilevel interventions expanding cancer screening and preventive services in populations experiencing health disparities.
Key Information: Clinical trials are required, targeting NIH-designated health disparity populations at two or more socio-ecological levels.
This R01 program, part of NIH’s ADVANCE prevention research effort, supports testing interventions that improve uptake of cancer screening and preventive services among NIH-designated populations experiencing health disparities. The Office of Disease Prevention coordinates the opportunity with the National Cancer Institute, National Institute of Dental and Craniofacial Research, and National Institute on Minority Health and Health Disparities. The Office of Research on Women’s Health may co-fund relevant awards.
Projects may improve screening, vaccination, referrals, timely follow-up of abnormal findings, and access to appropriate care. Interventions should address barriers and facilitators across patient, clinician, healthcare-setting, or neighborhood/community levels. Collaborations with community partners and service providers are encouraged, including delivery beyond primary care settings. Applications must align with a participating institute’s mission.